VPAC1 Targeted (64)Cu-TP3805 PET Imaging of Prostate Cancer: Preliminary Evaluation in Man.

To evaluate (64)Cu-TP3805 as a novel biomolecule, to PET image prostate cancer (PC), at the onset of which VPAC1, the superfamily of G-protein coupled receptors, is expressed in high density on PC cells, but not on normal cells.

25 patients undergoing radical prostatectomy were PET/CT imaged preoperatively with (64)Cu-TP3805. Standardized uptake values (SUVmax) were determined, malignant lesions (SUV > 1. 0) counted, and compared with histologic findings. Whole mount pathology slides from 6 VPAC1 PET imaged patients, 3 BPH patients, one malignant and one benign lymph node underwent digital autoradiography (DAR) after (64)Cu-TP3805 incubation and compared to H&E stained slides.

In 25 patient PET imaging, 212 prostate gland lesions had SUVmax > 1. 0 vs. 127 lesions identified by histology of biopsy tissues. The status of the additional 85 PET identified prostate lesions remains to be determined. In 68 histological slides from 6 PET imaged patients, DAR identified 105/107 PC foci, 19/19 HGPIN, and ejaculatory ducts and verumontanum involved with cancer. Additionally, DAR found 9 PC lesions not previously identified histologically. The positive and negative lymph nodes were correctly identified and in 3/3 BPH patients and 5/5 cysts, DAR was negative.

This feasibility study demonstrated that (64)Cu-TP3805 delineates PC in vivo and ex vivo, provided normal images for benign masses, and is worthy of further studies.

Urology. 2015 Oct 28 [Epub ahead of print]

Sushil Tripathi, Edouard J Trabulsi, Leonard Gomella, Sung Kim, Peter McCue, Charles Intenzo, Ruth Birbe, Ashish Gandhe, Pardeep Kumar, Mathew Thakur

Thomas Jefferson University, Department of Radiology. , Thomas Jefferson University, Department of Urology; Thomas Jefferson University, Sidney Kimmel Cancer Center. , Thomas Jefferson University, Department of Urology; Thomas Jefferson University, Sidney Kimmel Cancer Center. , Thomas Jefferson University, Department of Radiology. , Thomas Jefferson University, Department of Pathology; Thomas Jefferson University, Sidney Kimmel Cancer Center. , Thomas Jefferson University, Department of Radiology. , Thomas Jefferson University, Department of Pathology; Thomas Jefferson University, Sidney Kimmel Cancer Center. , Thomas Jefferson University, Department of Radiology. , Thomas Jefferson University, Department of Radiology. , Thomas Jefferson University, Department of Radiology; Thomas Jefferson University, Sidney Kimmel Cancer Center.  

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe